Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 16, Issue 3, Pages 209-219
Publisher
Springer Nature
Online
2016-01-26
DOI
10.1038/tpj.2015.95
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The noncoding human genome and the future of personalised medicine
- (2015) Philip Cowie et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Autologous Islet Transplantation in Patients Requiring Pancreatectomy for Neoplasm
- (2014) Gianpaolo Balzano et al. Current Diabetes Reports
- Pathways Targeted by Antidiabetes Drugs Are Enriched for Multiple Genes Associated With Type 2 Diabetes Risk
- (2014) Ayellet V. Segrè et al. DIABETES
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Mortality risk with sulphonylureas compared to metformin
- (2014) S. E. Holden et al. DIABETES OBESITY & METABOLISM
- CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients
- (2014) Jasna Klen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- ABCC8 genetic variants and risk of diabetes mellitus
- (2014) Polin Haghverdizadeh et al. GENE
- Association of the rs7903146 and rs12255372 polymorphisms in the TCF7L2 gene with type 2 diabetes in a population from northeastern Brazil
- (2014) C.M.A.R. Barros et al. GENETICS AND MOLECULAR RESEARCH
- Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass
- (2014) Ryan K. Mitchell et al. HUMAN MOLECULAR GENETICS
- TCF7L2 is a master regulator of insulin production and processing
- (2014) Yuedan Zhou et al. HUMAN MOLECULAR GENETICS
- Genetic markers for prediction of treatment outcomes in ovarian cancer
- (2014) E Caiola et al. PHARMACOGENOMICS JOURNAL
- Population Specific Impact of Genetic Variants in KCNJ11 Gene to Type 2 Diabetes: A Case-Control and Meta-Analysis Study
- (2014) Nagaraja M. Phani et al. PLoS One
- Meta-analysis of associations between TCF7L2 polymorphisms and risk of type 2 diabetes mellitus in the Chinese population
- (2013) Jinjin Wang et al. BMC Medical Genetics
- Association of rs12255372 in theTCF7L2 gene with type 2 diabetes mellitus: a meta-analysis
- (2013) Jinjin Wang et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Molecular Mechanism of Sulphonylurea Block of KATP Channels Carrying Mutations That Impair ATP Inhibition and Cause Neonatal Diabetes
- (2013) P. Proks et al. DIABETES
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Global estimates of diabetes prevalence for 2013 and projections for 2035
- (2013) L. Guariguata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China
- (2013) Qian Ren et al. DIABETOLOGIA
- Kir6.2E23K polymorphism is related to secondary failure of sulfonylureas in non-obese patients with type 2 diabetes
- (2013) Yoshinori Shimajiri et al. Journal of Diabetes Investigation
- Diabetes Mellitus and the β Cell: The Last Ten Years
- (2012) Frances M. Ashcroft et al. CELL
- Influence of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Sulfonylurea Drugs
- (2012) Hongmei Xu et al. CURRENT DRUG METABOLISM
- The KCNJ11 E23K gene polymorphism and type 2 diabetes mellitus in the Chinese Han population: a meta-analysis of 6,109 subjects
- (2012) Yan-yan Li MOLECULAR BIOLOGY REPORTS
- Meta-analysis of the effect of KCNQ1 gene polymorphism on the risk of type 2 diabetes
- (2012) Jun Liu et al. MOLECULAR BIOLOGY REPORTS
- Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus
- (2012) Hasniza Zaman Huri et al. International Journal of Clinical Pharmacy
- The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel
- (2011) Dimitry A. Chistiakov et al. ACTA DIABETOLOGICA
- TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes
- (2011) Andreas Holstein et al. BMC Medical Genetics
- Regulation of glucagon secretion by incretins
- (2011) J. J. Holst et al. DIABETES OBESITY & METABOLISM
- Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients
- (2011) A. Surendiran et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
- (2011) Martin Javorsky et al. European Journal of Internal Medicine
- Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
- (2011) Chunmei Huang et al. Genome Medicine
- Effect of genetic polymorphisms on the development of secondary failure to sulfonylurea in Egyptian patients with type 2 diabetes
- (2011) Alaa E. El-sisi et al. Therapeutic Advances in Endocrinology and Metabolism
- Genetic variants of the insulin receptor substrate-1 are influencing the therapeutic efficacy of oral antidiabetics
- (2010) A. Seeringer et al. DIABETES OBESITY & METABOLISM
- Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea
- (2010) Matthijs L. Becker et al. Pharmacogenetics and Genomics
- Metabolic Control in Type 2 Diabetes Is Associated with Sulfonylurea Receptor-1 (SUR-1) but Not with KCNJ11 Polymorphisms
- (2009) Nora Nikolac et al. ARCHIVES OF MEDICAL RESEARCH
- Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study
- (2009) K Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Type 2 Diabetes Susceptibility Gene TCF7L2 and Its Role in -Cell Function
- (2009) A. L. Gloyn et al. DIABETES
- Translating TCF7L2: from gene to function
- (2009) E. R. Pearson DIABETOLOGIA
- Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
- (2008) Y. Feng et al. DIABETES CARE
- Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes
- (2008) Valeriya Lyssenko et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now